Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic- Clonic Seizures
Enrolling By Invitation
18 years - 99 years
All
Phase
3
10 participants needed
1 Location
Brief description of study
The research study is being conducted to evaluate the long-term safety and tolerability
of cenobamate for Primary Generalized Tonic-Clonic (PGTC) seizures
Detailed description of study
You are being
invited to participate in this study because you have completed main study
YKP3089C025.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: epilepsy,seizures
-
Age: 18 years - 99 years
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 834015
If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu
